Methicillin-Resistant Staphylococcus aureus (MRSA) Is Increasing in Norway: A Time Series Analysis of Reported MRSA and Methicillin-Sensitive S. aureus Cases, 1997-2010

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Moxnes, John F ^a   de Blasio, Birgitte Freiesleben ^b,c   Leegaard, Truls Michael ^d   Moen, Aina E Fossum ^d  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; NORWAY; PRACTICE GUIDELINE; SEASONAL VARIATION; STOCHASTIC MODEL; TIME SERIES ANALYSIS; TREND STUDY;

METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NORWAY; RESEARCH REPORT; TIME FACTORS;

EID: 84880981306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070499     Document Type: Article

References (29)

1. Cohen ML, (1992) Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257: 1050-1055.
2. Shanson DC, (1981) Antibiotic-resistant Staphylococcus aureus. J Hosp Infect 2: 11-36.
3. Jevons MP, Rolinson GN, Knox R, (1961) Celbenin-resistant Staphylococci. Br Med J 1: 124-126.
4. Udo EE, Pearman JW, Grubb WB, (1993) Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 25: 97-108.
5. European Centre for Disease Prevention and Control (2010) Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC.
6. Jarvis WR, Jarvis AA, Chinn RY, (2012) National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 40: 194-200.
7. Elstrom P, Kacelnik O, Bruun T, Iversen B, Hauge SH, et al. (2012) Meticillin-resistant Staphylococcus aureus in Norway, a low-incidence country, 2006-2010. J Hosp Infect 80: 36-40.
8. National Institute of Public Health, The Norwegian Directorate of Health (2004) [Infection control 10 MRSA-guidelines]. Oslo: NIPH.
9. National Institute of Public Health, The Norwegian Directorate of Health (2009) [Infection control 16 MRSA-guidelines]. Oslo: NIPH.
10. Lopez-Lozano JM, Monnet DL, Yague A, Burgos A, Gonzalo N, et al. (2000) Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 14: 21-31.
11. Muller AA, Mauny F, Bertin M, Cornette C, Lopez-Lozano JM, et al. (2003) Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 36: 971-978.
12. Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, et al. (2008) Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 62: 601-607.
13. Aldeyab MA, Monnet DL, Lopez-Lozano JM, Hughes CM, Scott MG, et al. (2008) Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 62: 593-600.
14. Feng PJI, Kallen AJ, Ellingson K, Muder R, Jain R, et al. (2011) Clinical incidence of methicillin-resistant Staphylococcus aureus (MRSA) colonization or infection as a proxy measure for MRSA transmission in acute care hospitals. Infect Control Hosp Epidemiol 32: 20-25.
15. Ellingson K, Muder RR, Jain R, Kleinbaum D, Feng PJI, et al. (2011) Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention. Infect Control Hosp Epidemiol 32: 1-8.
16. Gebski V, Ellingson K, Edwards J, Jernigan J, Kleinbaum D, (2012) Modelling interrupted time series to evaluate prevention and control of infection in healthcare. Epidemiol Infect 140: 2131-2141.
17. Stone SP, Fuller C, Savage J, Cookson B, Hayward A, et al. (2012) Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 344: e3005.
18. Bertrand X, Lopez-Lozano JM, Slekovec C, Thouverez M, Hocquet D, et al. (2012) Temporal effects of infection control practices and the use of antibiotics on the incidence of MRSA. J Hosp Infect 82: 164-169.
19. Moxnes JF, Hausken K (2010) Introducing randomness into first-order and second-order deterministic differential equations. Adv Math Phys 1-42. DOI: 10.1155/2010/509326.
20. Hoef JMV, Boveng PL, (2007) Quasi-poisson vs. negative binomial regression: How should we model overdispersed count data? Ecology 88: 2766-2772.
21. Parienti JJ, Cattoir V, Thibon P, Lebouvier G, Verdon R, et al. (2011) Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis. J Hosp Infect 78: 118-122.
22. European Centre for Disease Prevention and Control (2010) European Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe 2010. Stockholm: ECDC.
23. Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM, (2012) Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother 67: 1010-1015.
24. Mostofsky E, Lipsitch M, Regev-Yochay G, (2011) Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus? J Antimicrob Chemother 66: 2199-2214.
25. Fossum AE, Bukholm G, (2006) Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year period. Clin Microbiol Infect 12: 627-633.
26. Moen AEF, Storla DG, Bukholm G, (2010) Distribution of methicillin-resistant Staphylococcus aureus in a low-prevalence area. FEMS Immunol Med Microbiol 58: 374-380.
27. Leekha S, Diekema DJ, Perencevich EN, (2012) Seasonality of staphylococcal infections. Clin Microbiol Infect 18: 927-933.
28. Leendert van der Werff HF, Steen TW, Garder KM, Andersen BM, Rasch M, et al. (2008) [An outbreak of MRSA in a nursing home in Oslo]. Tidsskr Nor Laegeforen 128: 2734-2737.
29. Andersen BM, Rasch M, Syversen G, (2007) Is an increase of MRSA in Oslo, Norway, associated with changed infection control policy? J Infect 55: 531-538.